When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OPNT - Opiant Pharmaceuticals receives $3M grant for OPNT003
Opiant Pharmaceuticals Inc.
Opiant Pharmaceuticals (NASDAQ:OPNT) has been awarded the second tranche of $3M from the total grant of ~$7.4M from the National Institutes of Health’s (“NIH”) National Institute on Drug Abuse (“NIDA”) for the development of OPNT003, nasal nalmefene, a long-acting opioid antagonist for the treatment of opioid overdose.
More news on: Opiant Pharmaceuticals, Inc., Healthcare stocks news,